This report provides an overview of the US molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test. Table of Contents Business Environment
1. Health Care Expenditures
2. Cost Consciousness
3. Reimbursement
4. Industry Consolidation
5. Managed Care
a. PPO
b. HMO
6. Hospitals
7. Admissions
8. Length of Stay
9. Industry Diversification
10. Physician Demographics
11. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
12. Laboratory Regulations
13. FDA Reform Market Structure
1. Hospitals
2. Commercial/Private Laboratories
3. Blood Banks
Market Size, Growth, and Major Suppliers' Market Shares
List of Tables Molecular Diagnostics Test Volume Forecasts by Application Molecular Diagnostic Sales Forecasts by Application Market Shares of Major Supplier of Molecular Diagnostic Tests Market Shares of Major Supplier of HIV/Hepatitis Blood Screening Assays Market Shares of Major Supplier of West Nile Virus Blood Screening Assays Contains 42 pages and 5 tables
|